Inception 4 Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $105M

Inception 4 General Information

Description

Developer of innovative therapeutics for patients with eye diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5871 Oberlin Drive
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 5871 Oberlin Drive
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inception 4 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Oct-2018 $105M Completed Product Development
1. Early Stage VC 30-Oct-2013 Completed Product Development
To view Inception 4’s complete valuation and funding history, request access »

Inception 4 Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Inception Sciences Accelerator/Incubator Majority
Versant Ventures Venture Capital Minority
To view Inception 4’s complete investors history, request access »

Inception 4 FAQs

  • When was Inception 4 founded?

    Inception 4 was founded in 2013.

  • Where is Inception 4 headquartered?

    Inception 4 is headquartered in San Diego, CA.

  • What industry is Inception 4 in?

    Inception 4’s primary industry is Biotechnology.

  • Is Inception 4 a private or public company?

    Inception 4 is a Private company.

  • What is the current valuation of Inception 4?

    The current valuation of Inception 4 is .

  • What is Inception 4’s current revenue?

    The current revenue for Inception 4 is .

  • How much funding has Inception 4 raised over time?

    Inception 4 has raised $5M.

  • Who are Inception 4’s investors?

    Inception Sciences and Versant Ventures have invested in Inception 4.

  • When was Inception 4 acquired?

    Inception 4 was acquired on 31-Oct-2018.

  • Who acquired Inception 4?

    Inception 4 was acquired by IVERIC bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »